Peter Schiff, a longtime Bitcoin critic, renewed his attack on Bitcoin's valuation and Michael Saylor's investment approach, calling current prices overpriced and warning of a potential market crash. Schiff compared Bitcoin's hype to past failed assets and labeled related ventures like Strategy's STRC as risky or even Ponzi schemes. In response, Saylor's team dismissed Schiff's criticism sarcastically, maintaining their bullish stance and continued Bitcoin accumulation. This ongoing clash highlights the divide in the crypto community and raises questions about Bitcoin's future price and investor sentiment.
LKQ Corporation announced it will publish its financial results for the second quarter of 2026 on July 30. The company will host a conference call and webcast with senior management to discuss the results, providing investors an opportunity to hear i...
First Federal Savings Bank and the Independent Community Bankers of America (ICBA) have issued 10 financial safety tips to help travelers manage their money securely during the summer travel season. Key advice includes notifying banks of travel plans...
Vivani Medical's wholly owned subsidiary Cortigent will merge with Nasdaq-listed ClearOne, which will be renamed Cortigent Holdings and trade under the ticker CRGT. Vivani will own a majority stake in the combined company, which will focus on advanci...
YD Bio Limited's U.S. affiliate, EG BioMed US, has secured clinical lab licenses in Rhode Island and Pennsylvania, expanding its CLIA-certified, CAP-accredited lab's footprint to 46 states plus D.C. and Guam. This expansion enhances patient access to...
Trust Stamp Inc has filed a US provisional patent for an AI-powered medical diagnostic support system called Medical Diagnostic Assurance System (MDAS). The system aims to help physicians evaluate diagnoses by reducing confirmation bias and AI halluc...
